Dow Geoffrey S's Form 4 filing
60 Degrees Pharmaceuticals, Inc. (SXTP) · filed Dec 9, 2024
- Accession no.
- 0001213900-24-107011
- Filed
- Dec 9, 2024
- Trade date
- Dec 5-9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $89.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dow Geoffrey SCIK 0001977231 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Common Stock | PPurchaseAcquired | +17,549 | $1.11 | +$19,479.39 | 38,178 | Direct | |
| Dec 6, 2024 | Common Stock | PPurchaseAcquired | +20,579 | $1.20 | +$24,694.8 | 58,757 | Direct | |
| Dec 9, 2024 | Common Stock | PPurchaseAcquired | +35,823 | $1.27 | +$45,495.21 | 94,580 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.